Mark Leonard Singleton - 20 Jun 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & CFO
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 20 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2023, 17:08:12 UTC
Previous filing: 12 Apr 2023
Next filing: 22 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BVS	Class A Common Stock						12,581	20 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Award	$0	+62,000		$0.000000	62,000	20 Jun 2023	Class A Common Stock	62,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date.